Sanford A. Stass

TL;DR: Immunohistochemical analysis of 303 clinical specimens from three independent cohorts of lung cancer patients and controls show that expression of ALDH1 is positively correlated with the stage and grade of lung tumors and related to a poor prognosis for the patients with early-stage lung cancer.

TL;DR: Investigating the stem-cell-related function and clinical significance of the ALDH1A1 in human PCa found it to be a prostate CSC-related marker and measuring its expression might provide a potential approach to study tumorigenesis of PCa and predict outcome of the disease.

TL;DR: The measurement of altered miRNA expression in sputum could be a useful noninvasive approach for the diagnosis of lung cancer.

TL;DR: The progress of analysis of microRNAs is reviewed as a potential approach for diagnosis and prognosis of solid cancer and obstacles in developing miRNAs as circulating biomarkers are discussed.

TL;DR: ALDH1A1 may serve as a useful marker for monitoring the progression of bladder tumor and identifying bladder cancer patients with poor prognosis who might benefit from adjuvant and effective treatments.